Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

KaloBios Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Trading Report for (KBIO). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for KBIO. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

29 Sep 2016 Stock Traders Daily 6 $20.00

KaloBios Pharmaceuticals, Inc. (KBIO) - Financial Analysis Review

KaloBios Pharmaceuticals, Inc. (KBIO) - Financial Analysis Review Summary KaloBios Pharmaceuticals, Inc. (KaloBios) is a deve...

13 Sep 2016 GlobalData 39 $300.00

"The Economy Matters" Report for KBIO: the economy's impact on KBIO's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

30 Aug 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

KaloBios Pharmaceuticals, Inc. (KBIO) - Financial Analysis Review

KaloBios Pharmaceuticals, Inc. (KBIO) - Financial Analysis Review Summary KaloBios Pharmaceuticals, Inc. (KaloBios) is a biop...

16 Jun 2016 GlobalData 48 $300.00

Value Graph: KALOBIOS PHARMA -- KBIOQ

03 Jun 2016 Ford Investor Services, Inc. 1 $12.00

KaloBios Pharmaceuticals, Inc. (KBIO) - Financial Analysis Review

KaloBios Pharmaceuticals, Inc. (KBIO) - Financial Analysis Review Summary KaloBios Pharmaceuticals, Inc. (KaloBios) is a biop...

17 Mar 2016 GlobalData 56 $300.00

ValuEngine Rating and Forecast Report for KBIOQ

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

07 Feb 2016 ValuEngine, Inc. 11 $25.00

ValuEngine Rating and Forecast Report for KBIO

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

10 Jan 2016 ValuEngine, Inc. 11 $25.00

Wright Investors Service Comprehensive Report for Kalobios Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

25 Dec 2015 Wright Reports 55 $75.00